SLC29A1 and cancer: Our cellular analyses showed that FTD incorporation into nuclear DNA in human cancer cell lines was effectively suppressed by an inhibitor of equilibrative nucleoside transporters (Fig. 6C) or by siRNA-mediated downregulation of SLC29A1 mRNA (Fig. 6E).